From new partnerships and launches, here are six developments from Globus Medical so far in 2025. 1. OsteoCentric Technologies entered into a non-exclusive licensing agreement with Globus Medical.

Globus Medical (NYSE:GMED) announced that its board of directors authorized a share repurchase program totaling up to $500 ...

On the heels of a first quarter sales dip, leaders remain confident in Globus Medical’s full-year success, according to a May 8 earnings call. 1. Globus Medical’s Excelsius robotic technologies are ...

Globus Medical, Inc. (NYSE: GMED) announced that its Board of Directors has authorized a share repurchase program of up to ...